Abstract

BackgroundInterleukin-37 (IL-37) is one of few anti-inflammatory cytokines produced mainly by monocytes and dendritic cells. Recent data suggest its role in several autoimmune diseases. The aim of this study was...

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
Syndecan-4 is correlated with disease activity and serological characteristic of rheumatoid arthritis
Xia Ye ... Zhuoli Zhang
Advances in Rheumatology | VOL. 62
Xia Ye, et. al.Xia Ye ... Zhuoli Zhang
20 Jun 2022
AB0075 PRESENCE AND EFFECT OF MUSCLE GDF-8 AND GDF-11 IN THE SYNOVIUM OF PATIENTS WITH RHEUMATOID ARTHRITIS
R Xavier ... R T Pedo
Annals of the Rheumatic Diseases | VOL. 82
R Xavier, et. al.R Xavier ... R T Pedo
30 May 2023
Epithelial neutrophil activating peptide-78: a novel chemotactic cytokine for neutrophils in arthritis.
D D Mazarakis ... G K Haines
Journal of Clinical Investigation | VOL. 94
D D Mazarakis, et. al.D D Mazarakis ... G K Haines
01 Sep 1994
Increased prevalence of semaphorin 3C, a repellent of sympathetic nerve fibers, in the synovial tissue of patients with rheumatoid arthritis.
Claudia Weidler ... Peter Angele
Arthritis and rheumatism | VOL. 50
Claudia Weidler, et. al.Claudia Weidler ... Peter Angele
01 Apr 2004
View more papers

More From: Annals of the Rheumatic Diseases

Paper Title
Journal
Date
Author
The associations between poorer pain-related health status and increased hospitalisations and excess mortality in patients with rheumatoid arthritis (RA): a prospective cohort analysis using the Australian Rheumatology Association Database (ARAD)
Huai Leng Pisaniello ... Samuel Lawrance Whittle
Annals of the Rheumatic Diseases | VOL. -
Huai Leng Pisaniello, et. al.Huai Leng Pisaniello ... Samuel Lawrance Whittle
29 May 2024
Integrated safety analysis of filgotinib in patients with moderate-to-severe rheumatoid arthritis over a treatment duration of up to 8.3 years
Gerd R Burmester ... Daniel Aletaha
Annals of the Rheumatic Diseases | VOL. -
Gerd R Burmester, et. al.Gerd R Burmester ... Daniel Aletaha
23 May 2024
BCMA-CD19 compound CAR T cells for systemic lupus erythematosus: a phase 1 open-label clinical trial
Weijia Wang ... Yong Yuan
Annals of the Rheumatic Diseases | VOL. -
Weijia Wang, et. al.Weijia Wang ... Yong Yuan
22 May 2024
Exploring the effect on primary endpoints in trials testing targeted therapy interventions for rheumatoid arthritis: a meta-epidemiological study on the appropriate use of a core outcome set
Philip Rask Lage-Hansen ... Robin Christensen
Annals of the Rheumatic Diseases | VOL. -
Philip Rask Lage-Hansen, et. al.Philip Rask Lage-Hansen ... Robin Christensen
22 May 2024
View more papers